Cell & Gene Exchange, May 2017: Cesca Therapeutics Inc.

June 16, 2017
Cesca is a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. Its device division provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Cesca is also leveraging its proprietary AutoXpress® technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the vascular, cardiology and orthopedic markets. Cesca is an affiliate of the BoyaLife Group, a China-based industry research alliance encompassing top research institutions for stem cell and regenerative medicine. Speaker: Dalip Sethi – Sr. Director, Research & Development
Previous Video
Cell & Gene Exchange, May 2017: bBHC-STRI
Cell & Gene Exchange, May 2017: bBHC-STRI

The STC Stem Cell Treatment & Research Institute-bBHC developed the pluripotent stem cell free from side ef...

Next Video
Cell & Gene Exchange, May 2017: Abeona Therapeutics Inc
Cell & Gene Exchange, May 2017: Abeona Therapeutics Inc

Abeona Therapeutics Inc. (NASDAQ:ABEO) is a clinical-stage biopharmaceutical company developing novel gene ...